[Trailer] FDA Greenlights Cancer Drug from China Amid Shortage | China in Focus

Cancer drugs are in short supply, and this problem is now gripping American health care. To help, the Food and Drug Administration (FDA) is greenlighting a cancer drug from China. Some applaud the decision, while others warn that Beijing could use medicines as a weapon against the United States by withholding supplies or selling drugs that lack effective ingredients. Topics in this episode: FDA Greenlights Cancer Drug from China Amid Shortage Sequoia Capital Separates Its U.S., China Business TikTok Stars' SSN Stored in China: Report Sec. of State Blinken to Visit China Soon: Report China, Russia Launch Joint Air Patrol near Japan 'Silent Barker': U.S. Spy Satellites to Counter China, Russia German Pilots Pass NATO's Tactics to China Russian Airspace Closure Slows Foreign Flights To, from China China's Wheat Growers Face 'Disaster' Amid Heavy Rain Cybersecurity Expert on 'Severe' Attack on U.S. Navy by Chinese Hackers